Asia-pacific Cough Syrup Market Forecast 2023-2032

The Asia-Pacific cough syrup market is set to project a CAGR of 4.01% during the forecast period, 2023-2032. Numerous nations in Asia-Pacific are experiencing aging populations, leading to an increased vulnerability among the elderly to respiratory diseases. This demographic shift has resulted in a growing demand for specialized cough syrups tailored to meet the specific requirements of this aging demographic.

MARKET INSIGHTS

South Korea, China, Vietnam, Australia & New Zealand, Indonesia, Japan, Thailand, India, and Rest of Asia-Pacific are analyzed for the Asia-Pacific cough syrup market growth evaluation. Respiratory illnesses like the common cold, flu, and cough-related conditions are becoming more common in South Korea. Recent health data indicates a rising prevalence of these respiratory disorders, affecting a significant portion of the population annually. Factors such as air pollution, seasonal variations, and lifestyle choices all contribute to the growing incidence of respiratory disorders, leading to an increased need for effective medications like cough syrups.

South Korea is currently undergoing a demographic transformation due to its aging population. A substantial portion of the population is aged 65 and above, and this demographic segment is expanding rapidly. Given that the elderly are more susceptible to respiratory infections, this demographic shift is driving up the demand for cough syrups, as this age group seeks reliable remedies for the common symptoms of coughs and colds.

Further, the increase in fatalities associated with cough syrup usage, along with the subsequent removal of five cough and fever syrup brands by the Indonesian Food and Drug Monitoring Agency in 2021, is expected to exert a substantial influence on Indonesia's cough syrup market.

COMPETITIVE INSIGHTS

Some of the key companies in the market are: Novartis AG, Merck KGaA, Pfizer Inc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 71444

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
- 2.4.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DIVERSIFICATION IS ON THE RISE
- 2.5.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
- 2.5.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
- 3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
- 3.2.2. STRINGENT REGULATORY PROTOCOLS
- 3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. INCREASING SELF-MEDICATION TRENDS
- 4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
- 4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
- 4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
- 4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR JAPAN
4.4. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT TYPE

5.1. COUGH SUPPRESSANTS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY AGE GROUP

6.1. ADULTS
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY DISTRIBUTION CHANNEL

7.1. RETAIL PHARMACIES
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. GEOGRAPHICAL ANALYSIS

8.1. ASIA-PACIFIC
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. ASIA-PACIFIC COUGH SYRUP MARKET DRIVERS
- 8.1.3. ASIA-PACIFIC COUGH SYRUP MARKET CHALLENGES
- 8.1.4. ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. CHINA
  - 8.1.6.1.1. CHINA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. JAPAN
  - 8.1.6.2.1. JAPAN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.3. INDIA
  - 8.1.6.3.1. INDIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.4. SOUTH KOREA
  - 8.1.6.4.1. SOUTH KOREA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.5. INDONESIA
  - 8.1.6.5.1. INDONESIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.6. THAILAND
  - 8.1.6.6.1. THAILAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.7. VIETNAM
  - 8.1.6.7.1. VIETNAM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.8. AUSTRALIA & NEW ZEALAND
  - 8.1.6.8.1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.9. REST OF ASIA-PACIFIC
  - 8.1.6.9.1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBOTT LABORATORIES
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT LIST
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. ACELLA PHARMACEUTICALS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT LIST
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. ASTRAZENECA PLC
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT LIST
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CIPLA LTD
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. DABUR INDIA LTD
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT LIST
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. GLENMARK PHARMACEUTICALS LTD
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. GSK PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT LIST
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. HIMALAYA WELLNESS COMPANY
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. KENVUE
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. MERCK KGAA
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT LIST
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. NOVARTIS AG
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. PFIZER INC
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCT LIST
  - 9.2.12.3. STRENGTHS & CHALLENGES
- 9.2.13. PROCTER & GAMBLE
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. PRODUCT LIST
  - 9.2.13.3. STRENGTHS & CHALLENGES
- 9.2.14. RECKITT BENCKISER GROUP PLC
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCT LIST
  - 9.2.14.3. STRENGTHS & CHALLENGES
- 9.2.15. SANOFI
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCT LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

Product Code: 71444

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - COUGH SYRUP MARKET
TABLE 2: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK
TABLE 11: KEY PLAYERS OPERATING IN ASIA-PACIFIC COUGH SYRUP MARKET
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: ASIA-PACIFIC COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022
FIGURE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2032 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2032 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2032 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022
FIGURE 10: ASIA-PACIFIC COUGH SYRUP MARKET, BY ADULTS, 2023-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2032 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022
FIGURE 14: ASIA-PACIFIC COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 18: CHINA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 19: JAPAN COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 20: INDIA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 21: SOUTH KOREA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: INDONESIA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: THAILAND COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: VIETNAM COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: REST OF ASIA-PACIFIC COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)